Literature DB >> 15686216

Susceptibility to lung tuberculosis--a population-genetic study.

Dragica Pesut1.   

Abstract

The aim of this study was to compare the genetic structure of lung tuberculosis (LTB) patients (Pts) to healthy controls i.e. to evaluate dependency of LTB occurrence and course of the disease in regard to subject's genetic constitution. The study group consisted of 100 LTB Pts, while the same number of healthy non-sibling individuals served as controls. The groups were analyzed with respect to homozygous recessive characteristics (HRC) that served as genetic markers, which were studied in each subject. Twenty-three HRCs were chosen according to HRC-test rules. The results show significant difference in average HRC number between two samples, a decreased number in Pts group, total cumulative chi2 difference (p<0.001) and frequency distribution (p = 0.0027). We conclude that the analyzed groups make two different samples in regard to their population-genetic structure. It means that they may give a different response to similar environmental agents. A significantly decreased HRC number in the Pts group may be a manifestation of their decreased degree of homozygosity and indicate a dominant factor inluence in predisposition to LTB. It is possible that individuals with such genetic and physiological constitution are more liable to infection/disease caused by M. tuberculosis. Deviation from optimal degree of homozygosity appoints to possibility of altered genetic-physiological organism homeostasis and its altered reaction norm that leads to illness. Particular phenotype distribution analysis of significantly decreased frequency of HRC and characteristic expression (eye and hair colour) suggest that there is a possibility of related gene alleles association with genetic basis for susceptibility to TB in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15686216

Source DB:  PubMed          Journal:  Med Pregl        ISSN: 0025-8105


  7 in total

1.  Gender and morphogenetic variability of patients with spina bifida occulta and spina bifida aperta: prospective population-genetic study.

Authors:  D Nikolic; I Petronic; S Cvjeticanin; R Brdar; D Cirovic; M Bizic; L Konstantinovic; D Matanovic
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

2.  Degree of genetic homozygosity and distribution of AB0 blood types among patients with spina bifida occulta and spina bifida aperta.

Authors:  Dejan Nikolic; Suzana Cvjeticanin; Ivana Petronic; Biljana Jekic; Radivoj Brdar; Tatjana Damnjanovic; Vera Bunjevacki; Nela Maksimovic
Journal:  Arch Med Sci       Date:  2010-12-29       Impact factor: 3.318

3.  Population-genetic Aspects of Breast Cancers and Association with Rh Factor in Selected Sample.

Authors:  Azra Metovic; Jasmin Musanovic; Nerman Ramic; Orhan Lepara; Damir Secic; Esad Pepic; Svjetlana Loga Zec; Senad Sljuka
Journal:  Med Arch       Date:  2021-12

4.  Population genetic analyses of susceptibility to increased body weight.

Authors:  Dejan Nikolic; Suzana Cvjeticanin; Ivana Petronic; Zeljka Milincic; Radivoj Brdar; Radmila Karan; Ljubica Konstantinovic; Aleksandra Dragin; Milisav Cutovic
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318

5.  Simoultaneuos occurence of other diseases among prison inmates with tuberculosis.

Authors:  Tanta Cernat; Maria Comanescu; D Alexandru; V Carlig
Journal:  Curr Health Sci J       Date:  2010-09-21

6.  The Gender Impact on Morphogenetic Variability in Coronary Artery Disease: A Preliminary Study.

Authors:  Radmila Karan; Biljana Obrenovic-Kircanski; Suzana Cvjeticanin; Natasa Kovacevic-Kostic; Milos Velinovic; Vladimir Milicevic; Milica Vranes-Stoimirov; Dejan Nikolic
Journal:  J Clin Med       Date:  2018-05-03       Impact factor: 4.241

7.  Genetic and Environmental Dispositions for Cardiovascular Variability: A Pilot Study.

Authors:  Radmila Karan; Suzana Cvjeticanin; Natasa Kovacevic-Kostic; Dejan Nikolic; Milos Velinovic; Vladimir Milicevic; Biljana Obrenovic-Kircanski
Journal:  J Clin Med       Date:  2018-08-23       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.